Form 4: AngioDynamics Director Reed Jan Stern Acquires Shares as Part of Compensation Package

Director Reed Jan Stern acquired 20,541 shares of AngioDynamics common stock as part of his annual compensation, which immediately vested.

Summary

• On July 17, 2024, Reed Jan Stern, a director of AngioDynamics Inc. (ANGO), acquired 20,541 shares of common stock.
• The acquisition represents restricted stock units granted as annual compensation for his service as a director.
• These restricted stock units vested immediately upon grant.
• Following the transaction, Stern directly owns 87,359 shares of AngioDynamics.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard compensation practice. The director receiving stock units is generally a positive sign, but it's not a major event that would significantly impact the company's outlook.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

Director compensation in the form of stock options and restricted stock units is a common practice in publicly traded companies to align the interests of management with those of shareholders.

Comparison to Industry Standards

• Granting restricted stock units as part of director compensation is a standard practice among publicly traded companies, including those in the medical device industry like Medtronic, Boston Scientific, and Abbott Laboratories.
• The specific amount and vesting schedule can vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder confidence.

Key Dates